Logo image of EMX

EMX ROYALTY CORP (EMX) Stock Fundamental Analysis

USA - NYSE Arca - NYSEARCA:EMX - CA26873J1075 - Common Stock

4.16 USD
+0.11 (+2.72%)
Last: 11/12/2025, 8:16:25 PM
4.07 USD
-0.09 (-2.16%)
After Hours: 11/12/2025, 8:16:25 PM
Fundamental Rating

5

Taking everything into account, EMX scores 5 out of 10 in our fundamental rating. EMX was compared to 156 industry peers in the Metals & Mining industry. EMX has a great financial health rating, but its profitability evaluates not so good. EMX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

EMX had positive earnings in the past year.
In the past year EMX had a positive cash flow from operations.
In the past 5 years EMX reported 4 times negative net income.
In multiple years EMX reported negative operating cash flow during the last 5 years.
EMX Yearly Net Income VS EBIT VS OCF VS FCFEMX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

With a decent Return On Assets value of 3.31%, EMX is doing good in the industry, outperforming 66.23% of the companies in the same industry.
EMX has a Return On Equity of 4.19%. This is in the better half of the industry: EMX outperforms 62.99% of its industry peers.
EMX has a Return On Invested Capital of 2.64%. This is comparable to the rest of the industry: EMX outperforms 54.55% of its industry peers.
Industry RankSector Rank
ROA 3.31%
ROE 4.19%
ROIC 2.64%
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.31%
ROIC(3y)N/A
ROIC(5y)N/A
EMX Yearly ROA, ROE, ROICEMX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

EMX has a better Profit Margin (16.27%) than 81.17% of its industry peers.
EMX has a better Operating Margin (15.94%) than 70.78% of its industry peers.
Industry RankSector Rank
OM 15.94%
PM (TTM) 16.27%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMX Yearly Profit, Operating, Gross MarginsEMX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EMX is destroying value.
EMX has less shares outstanding than it did 1 year ago.
EMX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EMX has a worse debt to assets ratio.
EMX Yearly Shares OutstandingEMX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EMX Yearly Total Debt VS Total AssetsEMX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 12.53 indicates that EMX is not in any danger for bankruptcy at the moment.
EMX has a better Altman-Z score (12.53) than 79.87% of its industry peers.
The Debt to FCF ratio of EMX is 9.09, which is on the high side as it means it would take EMX, 9.09 years of fcf income to pay off all of its debts.
EMX's Debt to FCF ratio of 9.09 is fine compared to the rest of the industry. EMX outperforms 61.04% of its industry peers.
EMX has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
EMX has a Debt to Equity ratio (0.22) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 9.09
Altman-Z 12.53
ROIC/WACC0.3
WACC8.74%
EMX Yearly LT Debt VS Equity VS FCFEMX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

EMX has a Current Ratio of 7.95. This indicates that EMX is financially healthy and has no problem in meeting its short term obligations.
EMX's Current ratio of 7.95 is amongst the best of the industry. EMX outperforms 86.36% of its industry peers.
EMX has a Quick Ratio of 7.95. This indicates that EMX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 7.95, EMX belongs to the best of the industry, outperforming 87.01% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.95
Quick Ratio 7.95
EMX Yearly Current Assets VS Current LiabilitesEMX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 294.55% over the past year.
Looking at the last year, EMX shows a decrease in Revenue. The Revenue has decreased by -8.72% in the last year.
EMX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.11% yearly.
EPS 1Y (TTM)294.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.19%
Revenue 1Y (TTM)-8.72%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%4.05%

3.2 Future

Based on estimates for the next years, EMX will show a very strong growth in Earnings Per Share. The EPS will grow by 71.00% on average per year.
The Revenue is expected to grow by 10.78% on average over the next years. This is quite good.
EPS Next Y233.33%
EPS Next 2Y100%
EPS Next 3Y71%
EPS Next 5YN/A
Revenue Next Year15.63%
Revenue Next 2Y9.51%
Revenue Next 3Y10.78%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
EMX Yearly Revenue VS EstimatesEMX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
EMX Yearly EPS VS EstimatesEMX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 -0.1 -0.15

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 104.00, which means the current valuation is very expensive for EMX.
EMX's Price/Earnings is on the same level as the industry average.
EMX is valuated expensively when we compare the Price/Earnings ratio to 26.39, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 94.81, which means the current valuation is very expensive for EMX.
EMX's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of EMX to the average of the S&P500 Index (23.84), we can say EMX is valued expensively.
Industry RankSector Rank
PE 104
Fwd PE 94.81
EMX Price Earnings VS Forward Price EarningsEMX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

EMX's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as EMX.
Industry RankSector Rank
P/FCF 232.63
EV/EBITDA 58.49
EMX Per share dataEMX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EMX's earnings are expected to grow with 71.00% in the coming years.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y100%
EPS Next 3Y71%

0

5. Dividend

5.1 Amount

No dividends for EMX!.
Industry RankSector Rank
Dividend Yield N/A

EMX ROYALTY CORP

NYSEARCA:EMX (11/12/2025, 8:16:25 PM)

After market: 4.07 -0.09 (-2.16%)

4.16

+0.11 (+2.72%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-07 2025-11-07
Earnings (Next)03-10 2026-03-10
Inst Owners22.14%
Inst Owner Change9.08%
Ins Owners14.94%
Ins Owner ChangeN/A
Market Cap454.19M
Revenue(TTM)29.86M
Net Income(TTM)4.86M
Analysts84.44
Price Target4.26 (2.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)116.51%
Min EPS beat(2)35.92%
Max EPS beat(2)197.09%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 104
Fwd PE 94.81
P/S 21.42
P/FCF 232.63
P/OCF 44.15
P/B 5.51
P/tB 5.51
EV/EBITDA 58.49
EPS(TTM)0.04
EY0.96%
EPS(NY)0.04
Fwd EY1.05%
FCF(TTM)0.02
FCFY0.43%
OCF(TTM)0.09
OCFY2.27%
SpS0.19
BVpS0.75
TBVpS0.75
PEG (NY)0.45
PEG (5Y)N/A
Graham Number0.82
Profitability
Industry RankSector Rank
ROA 3.31%
ROE 4.19%
ROCE 3.34%
ROIC 2.64%
ROICexc 3.17%
ROICexgc 3.17%
OM 15.94%
PM (TTM) 16.27%
GM N/A
FCFM 9.21%
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 9.09
Debt/EBITDA 2.31
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.84
Cash Conversion 133.67%
Profit Quality 56.58%
Current Ratio 7.95
Quick Ratio 7.95
Altman-Z 12.53
F-Score7
WACC8.74%
ROIC/WACC0.3
Cap/Depr(3y)25.77%
Cap/Depr(5y)19.56%
Cap/Sales(3y)6.62%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)294.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.19%
EPS Next Y233.33%
EPS Next 2Y100%
EPS Next 3Y71%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.72%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%4.05%
Revenue Next Year15.63%
Revenue Next 2Y9.51%
Revenue Next 3Y10.78%
Revenue Next 5YN/A
EBIT growth 1Y0.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3429.69%
EBIT Next 3Y256.52%
EBIT Next 5YN/A
FCF growth 1Y179.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y622.92%
OCF growth 3YN/A
OCF growth 5YN/A

EMX ROYALTY CORP / EMX FAQ

What is the fundamental rating for EMX stock?

ChartMill assigns a fundamental rating of 5 / 10 to EMX.


What is the valuation status of EMX ROYALTY CORP (EMX) stock?

ChartMill assigns a valuation rating of 3 / 10 to EMX ROYALTY CORP (EMX). This can be considered as Overvalued.


Can you provide the profitability details for EMX ROYALTY CORP?

EMX ROYALTY CORP (EMX) has a profitability rating of 3 / 10.


What is the valuation of EMX ROYALTY CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EMX ROYALTY CORP (EMX) is 104 and the Price/Book (PB) ratio is 5.51.


Can you provide the expected EPS growth for EMX stock?

The Earnings per Share (EPS) of EMX ROYALTY CORP (EMX) is expected to grow by 233.33% in the next year.